Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Mise à jour : Il y a 4 ans
Référence : NCT01569087

Femme Homme

Extrait

The purpose of the study is to compare safety and efficacy of a single dose of empegfilgrastimt a dose of 3 or 6 mg versus daily administration of filgrastim at a dose of 5 μg/kg/day.


Critère d'inclusion

  • Chemotherapy induced Neutropenia

Liens